SCHEMBL6022707

SCHEMBL6022707

CCCCOc1cc(CN2CCN(c3ccc(N=C(N)c4ccc[nH]4)cc3)CC2)cc(OCCCC)c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
MAPT P10636 5/20 0.39
KDM4E B2RXH2 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GAA P10253 5/20 0.37
TDP1 Q9NUW8 1/20 0.37
DRD4 P21917 3/20 0.36
DRD2 P14416 3/20 0.36
DRD3 P35462 3/20 0.36
PLA2G2A P14555 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.34
MEN1 O00255 1/20 0.34
CYP2D6 P10635 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7033277 0.97 MAPT (0.37) ALDH1A1MAPTKDM4ESMN1; SMN2NPSR1
SCHEMBL6023363 0.82 NOS3 (0.41)
SCHEMBL6022703 0.82 MAPT (0.43) ALDH1A1MAPTKDM4ESMN1; SMN2GAA
SCHEMBL6022488 0.81 MEN1 (0.47) GAATDP1MEN1RAB9AKMT2A
SCHEMBL6023942 0.81 ALDH1A1 (0.47) ALDH1A1MAPTKDM4EGAATDP1
SCHEMBL6022573 0.80 NOS3 (0.40)
SCHEMBL7033271 0.79 MAPT (0.40) ALDH1A1MAPTKDM4ESMN1; SMN2GAA
SCHEMBL6023985 0.79 MEN1 (0.50) GAATDP1MEN1KMT2A
SCHEMBL6023702 0.78 MEN1 (0.51) GAATDP1MEN1KMT2A
SCHEMBL6022708 0.78 MEN1 (0.51) GAATDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US claimed
US-7078407-B2 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2006-07-18 US disclosed
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them HTT, PARK7, NQO1 ALDH1A1 804/4885MAPT 69/4885KDM4E 1388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.